The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[(2-Fluoro-benzenesulfonylamino)-methyl]-cyclohexanecarboxylic acid (6-fluoro-1-pyridin-3-ylmethyl-1,2,3,4-tetrahydro-naphthalen-2-yl)-amide ID: ALA3084904
Max Phase: Preclinical
Molecular Formula: C30H33F2N3O3S
Molecular Weight: 553.68
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NC1CCc2cc(F)ccc2C1Cc1cccnc1)[C@H]1CC[C@H](CNS(=O)(=O)c2ccccc2F)CC1
Standard InChI: InChI=1S/C30H33F2N3O3S/c31-24-12-13-25-23(17-24)11-14-28(26(25)16-21-4-3-15-33-18-21)35-30(36)22-9-7-20(8-10-22)19-34-39(37,38)29-6-2-1-5-27(29)32/h1-6,12-13,15,17-18,20,22,26,28,34H,7-11,14,16,19H2,(H,35,36)/t20-,22-,26?,28?
Standard InChI Key: YSNXGFNZCPGGMB-KBFVXFJFSA-N
Molfile:
RDKit 2D
39 43 0 0 1 0 0 0 0 0999 V2000
10.0510 -1.1996 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.1022 -2.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2524 -3.2973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5361 -3.7179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6679 -2.4900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6679 -3.3086 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9687 -3.7179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5361 -4.5366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2324 -1.2507 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9998 -0.3809 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.8696 -1.1597 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8198 -3.3086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8355 -2.3763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3842 -2.0807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2524 -2.4787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8198 -4.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9687 -2.0807 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2524 -4.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9687 -4.5366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8368 -0.8357 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3842 -1.2507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1176 -2.4900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1035 -4.5366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5331 -0.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1035 -3.7179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5348 -1.9613 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.5361 -2.0694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4042 -4.9346 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.1005 -0.8357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8168 -2.0807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4200 -2.4729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8168 -1.2507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5361 -1.2450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1035 -1.2450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8867 -3.1950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8198 -2.4900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4711 -3.2916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1035 -2.0694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2215 -3.6555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 7 1 0
4 3 1 0
14 5 1 1
6 5 1 0
7 6 1 0
8 18 1 0
9 1 1 0
10 1 2 0
11 1 2 0
12 4 2 0
13 2 1 0
14 22 1 0
15 3 1 0
16 8 2 0
17 5 2 0
18 19 1 0
19 7 1 0
20 33 1 0
21 29 1 0
22 30 1 0
23 16 1 0
24 9 1 0
25 12 1 0
26 13 1 0
27 15 1 0
28 23 1 0
29 32 1 0
30 32 1 0
31 2 2 0
32 24 1 6
33 27 2 0
34 38 1 0
35 13 2 0
36 27 1 0
37 31 1 0
38 36 2 0
39 37 2 0
39 35 1 0
14 21 1 0
8 4 1 0
23 25 2 0
34 20 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 553.68Molecular Weight (Monoisotopic): 553.2211AlogP: 4.90#Rotatable Bonds: 8Polar Surface Area: 88.16Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.70CX Basic pKa: 4.93CX LogP: 5.13CX LogD: 5.11Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.42Np Likeness Score: -1.17
References 1. Youngman MA, McNally JJ, Lovenberg TW, Reitz AB, Willard NM, Nepomuceno DH, Wilson SJ, Crooke JJ, Rosenthal D, Vaidya AH, Dax SL.. (2000) alpha-Substituted N-(sulfonamido)alkyl-beta-aminotetralins: potent and selective neuropeptide Y Y5 receptor antagonists., 43 (3): [PMID:10669561 ] [10.1021/jm990468g ]